Remifentanil

Generic Name
Remifentanil
Brand Names
Ultiva
Drug Type
Small Molecule
Chemical Formula
C20H28N2O5
CAS Number
132875-61-7
Unique Ingredient Identifier
P10582JYYK
Background

Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

Indication

For use during the induction and maintenance of general anesthesia.

Associated Conditions
-
Associated Therapies
Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Clinical Trials
Related News

Postoperative Sedation After Cardiac Surgery

First Posted Date
2015-07-02
Last Posted Date
2017-05-17
Lead Sponsor
Hopital Foch
Target Recruit Count
19
Registration Number
NCT02488486
Locations
🇫🇷

Clinique Ambroise Paré, Neuilly-sur-Seine, Hauts-de-Seine, France

The Effects of Remifentanil and Remifentanil-Alfentanil Administration in Children

First Posted Date
2015-07-01
Last Posted Date
2015-07-07
Lead Sponsor
Hallym University Medical Center
Target Recruit Count
102
Registration Number
NCT02486926

The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy

First Posted Date
2015-07-01
Last Posted Date
2020-09-03
Lead Sponsor
Ufuk University
Target Recruit Count
103
Registration Number
NCT02486328

Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery

First Posted Date
2015-06-30
Last Posted Date
2023-12-20
Lead Sponsor
Recep Tayyip Erdogan University
Target Recruit Count
88
Registration Number
NCT02484859
Locations
🇹🇷

Recep Tayyip Erdogan University, Rize, Eastern Blacksea, Turkey

Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care During Vertebroplasty and Kyphoplasty

First Posted Date
2015-06-22
Last Posted Date
2015-06-24
Lead Sponsor
Hallym University Medical Center
Target Recruit Count
75
Registration Number
NCT02476981
Locations
🇰🇷

Hallym University Sacred Heart Hospital, Anyang-si, Dongan-gu, Korea, Republic of

Predictors of Opioid-Induced Respiratory Depression (OIRD)

First Posted Date
2015-06-16
Last Posted Date
2020-03-10
Lead Sponsor
Duke University
Target Recruit Count
30
Registration Number
NCT02473354
Locations
🇺🇸

Duke University Health Systems, Durham, North Carolina, United States

Comparision Between Hemodynamic Response of Dexmedetomidine and Remifentanil on Anesthesia in Endoscopic Sinus Surgery

First Posted Date
2015-06-08
Last Posted Date
2015-07-27
Lead Sponsor
Korea University Anam Hospital
Target Recruit Count
50
Registration Number
NCT02464722

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

First Posted Date
2015-05-27
Last Posted Date
2016-07-19
Lead Sponsor
Brasilia University Hospital
Target Recruit Count
30
Registration Number
NCT02454868

Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth

First Posted Date
2015-05-19
Last Posted Date
2016-07-26
Lead Sponsor
Brno University Hospital
Target Recruit Count
66
Registration Number
NCT02447757
Locations
🇨🇿

KDAR - department of pediatrics anesthesia and resuscitation, Brno, Czech Republic

🇨🇿

Sokolov Hospital, Sokolov, Czech Republic

Optimal Sevoflurane Concentration for Intubation in Combination of Clincal Remifentanil Doses

First Posted Date
2015-05-12
Last Posted Date
2019-01-17
Lead Sponsor
Severance Hospital
Target Recruit Count
68
Registration Number
NCT02440204
Locations
🇰🇷

Armed Forces Capital Hospital, Republic of Korea, Seongnam-si, Kyung-ki Do, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy